Fukagawa M - Search Results

1

Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters.

Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, Moe SM, Shroff R, Tonelli MA, Toussaint ND, Vervloet MG, Leonard MB. Ketteler M, et al. Among authors: fukagawa m. Kidney Int. 2017 Jul;92(1):26-36. doi: 10.1016/j.kint.2017.04.006. Kidney Int. 2017. PMID: 28646995 Free article. Review.

2

Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy.

Martin KJ, Olgaard K, Coburn JW, Coen GM, Fukagawa M, Langman C, Malluche HH, McCarthy JT, Massry SG, Mehls O, Salusky IB, Silver JM, Smogorzewski MT, Slatopolsky EM, McCann L; Bone Turnover Work Group. Martin KJ, et al. Among authors: fukagawa m. Am J Kidney Dis. 2004 Mar;43(3):558-65. doi: 10.1053/j.ajkd.2003.12.003. Am J Kidney Dis. 2004. PMID: 14981615 Review. No abstract available.

3

Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients.

Kazama JJ, Sato F, Omori K, Hama H, Yamamoto S, Maruyama H, Narita I, Gejyo F, Yamashita T, Fukumoto S, Fukagawa M. Kazama JJ, et al. Among authors: fukagawa m. Kidney Int. 2005 Mar;67(3):1120-5. doi: 10.1111/j.1523-1755.2005.00178.x. Kidney Int. 2005. PMID: 15698453 Free article.

4

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

Nakanishi S, Kazama JJ, Nii-Kono T, Omori K, Yamashita T, Fukumoto S, Gejyo F, Shigematsu T, Fukagawa M. Nakanishi S, et al. Among authors: fukagawa m. Kidney Int. 2005 Mar;67(3):1171-8. doi: 10.1111/j.1523-1755.2005.00184.x. Kidney Int. 2005. PMID: 15698459 Free article.

5

[Chronic kidney disease-mineral and bone disorder (CKD-MBD)].

Hamada Y, Fukagawa M. Hamada Y, et al. Among authors: fukagawa m. Nihon Rinsho. 2006 Sep;64(9):1703-6. Nihon Rinsho. 2006. PMID: 16972683 Review. Japanese.

6

Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).

Komaba H, Tanaka M, Fukagawa M. Komaba H, et al. Among authors: fukagawa m. Intern Med. 2008;47(11):989-94. doi: 10.2169/internalmedicine.47.1051. Epub 2008 Jun 2. Intern Med. 2008. PMID: 18520108 Free article. Review.

7

[Chronic kidney disease (CKD) and bone. The mechanisms of chronic kidney disease--mineral and bone disorder (CKD-MBD)].

Hamada Y, Fukagawa M. Hamada Y, et al. Among authors: fukagawa m. Clin Calcium. 2009 Apr;19(4):486-92. Clin Calcium. 2009. PMID: 19329826 Review. Japanese.

8

Is hepcidin the star player in iron metabolism in chronic kidney disease?

Hamada Y, Fukagawa M. Hamada Y, et al. Among authors: fukagawa m. Kidney Int. 2009 May;75(9):873-4. doi: 10.1038/ki.2009.46. Kidney Int. 2009. PMID: 19367309 Free article.

9

Management of mineral and bone disorder in chronic kidney disease: quo vadis?

Nakai K, Komaba H, Fukagawa M. Nakai K, et al. Among authors: fukagawa m. Ther Apher Dial. 2009 Oct;13 Suppl 1:S2-6. doi: 10.1111/j.1744-9987.2009.00767.x. Ther Apher Dial. 2009. PMID: 19765254 Review.

10

FGF23-parathyroid interaction: implications in chronic kidney disease.

Komaba H, Fukagawa M. Komaba H, et al. Among authors: fukagawa m. Kidney Int. 2010 Feb;77(4):292-8. doi: 10.1038/ki.2009.466. Epub 2009 Dec 9. Kidney Int. 2010. PMID: 20010546 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

620 results

Search Page

Filters